Back to Database
limited clinical and preclinical research

MOTS-c

MOTS-c

Neurology, Aging & Mitochondria

MOTS-c is a mitochondrial-derived peptide studied for metabolic and stress-response signaling, but longevity, fat-loss, and energy claims remain much less certain than the online hype suggests.

Research status: limited clinical and preclinical research

Deep Dives on MOTS-c

Start here for the plain-English articles connected to this peptide.

research_other11 min read

FDA’s Peptide Compounding Policy Reached White House Review—What That Does (and Does Not) Change

FDA’s peptide compounding policy entered OIRA review in October 2026. Learn what Executive Order 12866 review means—and what it does not change.

Read article
Research Guides11 min read

Can MOTS-c Protect the Diabetic Retina? What the New Cell and Mouse Study Shows

A 2026 study linked MOTS-c to retinal endothelial and mitochondrial protection signals in cultured cells and diabetic mice, with PLA2G6 acting as a model-level mediator—not proof of a human treatment.

Read article
mitochondrial_longevity12 min read

Is MOTS-c a Host-Defense Peptide? What the New MRSA Study Actually Shows

A 2026 eLife paper supports MOTS-c as a mitochondrial host-defense peptide in bacterial, cell, and mouse experiments—but it did not test MOTS-c as an infection treatment in people.

Read article
research_other8 min read

FDA Panel Backed Six Peptides for Compounding—What the Vote Does (and Does Not) Mean

The FDA advisory panel backed 503A Bulks List inclusion for the free-base and acetate forms of six peptide groups and rejected emideltide/DSIP. Here is what the non-binding vote means—and what it does not prove.

Read article
immune_inflammatory12 min read

Peptides for Long COVID: What Is Being Studied—and What Is Only Being Marketed

No peptide is proven to treat Long COVID. Separate controlled trials of tirzepatide and larazotide from planned research, animal studies, anecdotes, and marketing.

Read article
Regulation & Evidence11 min read

FDA Research Peptide Compounding Review: What It Is and What It Is Not

A cautious explainer on FDA's July 2026 review of seven peptide-related bulk drug substances for the 503A Bulks List, why staff opposition matters, and why the review is not FDA approval or proof of safety.

Read article
Compound Profiles10 min read

What Is Epitalon? Longevity Claims, Telomeres, and the Evidence Gap

Epitalon is searched as a telomere and longevity peptide, but the evidence is strongest for cell and animal biology and much weaker for proven human anti-aging outcomes.

Read article
Compound Profiles10 min read

What Is MOTS-c? The Mitochondrial Peptide People Are Searching For

MOTS-c is a mitochondrial-derived peptide studied for metabolic and stress-response signaling, but longevity, fat-loss, and energy claims remain much less certain than the online hype suggests.

Read article

Quick Facts

Origin
Peptide topic covered by the article "What Is MOTS-c? The Mitochondrial Peptide People Are Searching For"
Category
Neurology, Aging & Mitochondria

Mechanisms

  • Mitochondrial-derived peptide identity and mechanism literature
  • stress-response and AMPK-related pathway discussion
  • preclinical metabolic-homeostasis and insulin-resistance models
  • registered Phase 2a human trial for insulin sensitivity in adults with prediabetes and overweight/obesity, recruiting as of 2026-05-26

Research Areas

Articlemots c benefitsmots c peptide benefitsmots c side effectsRegulation & Evidenceresearch_otherimmune_inflammatorymitochondrial_longevity

Tags

mots-cmitochondrial open reading frame of the 12s rrna type-cmitochondrial-derived peptide mots-cmots c benefitsmots c peptide benefitspeptidenamed peptide